TPST

NASDAQ

Tempest Therapeutics

$1.56
+0.00 (+0.00%)

Income Statement

Total Revenue

In Millions USD
2016 $1M
2017 $0M
2018 $0M
2019 $0M
2020 $0M
2021 $0M
2022 $0M
2023 $0M
2024 $0M
2025 $0M

Net Income

In Millions USD
2016 $-82M
2017 $-85M
2018 $-27M
2019 $-45M
2020 $-19M
2021 $-28M
2022 $-36M
2023 $-29M
2024 $-42M
2025 $-26M

Profit Margins

Gross Operating Net

Detailed Income Statement

Item 2025 2024 2023 2022 2021
Total Revenue - - - - -
Cost of Revenue - $389K $381K $2M $1M
Gross Profit - $-389K $-381K $-2M $-1M
Operating Expenses - - - - -
Operating Income $-27M $-42M $-29M $-35M $-27M
Net Income $-26M $-42M $-29M $-36M $-28M
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00